Viewing nowTeroben Tablets (Terbinafine Hydrochloride)
Terbinafine Hydrochloride 140.625mg
Tablet · Prescription medication
Nexpharm Korea Co., Ltd.

MFDS item code 201908449 · Approved 2019.12.16 · Insurance code 662504320
Treatment of dermatophyte infections (tinea pedis, tinea corporis, etc.) and onychomycosis
This medication is used to treat various dermatophytoses caused by dermatophytes, such as tinea pedis, tinea corporis, and tinea capitis in adults. It is also used to treat tinea capitis in children.
As terbinafine, administer 125 mg once or twice daily, or 250 mg once daily. The treatment duration varies by disease as follows: 1) Dermatophyte infections. Tinea pedis (interdigital type, plantar type/moccasin type): 2-6 weeks. Tinea corporis: 2-4 weeks. Tinea cruris: 2-4 weeks. 2) Onychomycosis. Typically administered for 6 weeks to 3 months. If the infection is in the toenail or a relatively small toe, or if the patient is young, the treatment period may be shortened to less than 3 months. The treatment period is usually sufficient at 3 months for toenail infections, but in some patients, it may take 6 months or longer. For patients with slow nail growth, the treatment duration may be longer.
Administer to children over 2 years of age. Tinea capitis: 4 weeks. 1) For children weighing less than 20 kg (under 5 years): administer 62.5 mg once daily. 2) For children weighing 20-40 kg (5-12 years):
This medication should not be used in patients with chronic liver disease or active liver disease. It is essential to check for any history of liver disease before using this medication. Liver function tests should be conducted before treatment and regularly monitored during treatment as liver function issues may arise. If liver function test results worsen, this medication should be discontinued immediately. If symptoms such as nausea, loss of appetite, fatigue, vomiting, upper right abdominal pain, jaundice, dark urine, or diarrhea occur while taking this medication, contact a doctor immediately. This medication can cause severe liver damage, such as liver failure, and should be discontinued if liver damage is suspected. Patients with allergies to this medication, blood disorders, severe renal failure, children under 2 years of age, and nursing mothers should not use this medication. Specifically, patients with lactose intolerance or certain genetic disorders should not take this medication. Caution is advised when using this medication in patients with reduced kidney function, elderly patients, and children weighing less than 20 kg. Rarely, severe skin reactions may occur, so if rashes or unusual symptoms develop, discontinue use immediately. This medication should only be used for treating fungal infections and should not be used if local treatment is possible. Dizziness and other symptoms may occur, so care should be taken when driving or operating machinery. Potential interactions may occur with other medications, so inform your doctor or pharmacist if you are currently taking any other medications. Women who are pregnant or may become pregnant should carefully consider the benefits and risks of using this medication, and nursing mothers should discontinue breastfeeding while using it. Overdosage may lead to headache, nausea, upper abdominal pain, and dizziness, requiring immediate medical attention. This medication should be stored out of reach of children, away from direct sunlight, and at room temperature.
Hives, facial swelling, lymphangitis, biliary tract failure, hepatitis, cholestasis, jaundice, neutropenia, pancytopenia, agranulocytosis, thrombocytopenia, Stevens-Johnson syndrome, toxic epidermal necrolysis (Lyell syndrome), acute generalized exanthematous pustulosis, erythema multiforme, toxic skin eruptions, exfoliative dermatitis, blistering dermatitis, hypotension, dyspnea, chest pressure, anaphylactic reaction (angioedema, superficial and systemic
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly sealed container to prevent air exposure, ideally at room temperature between 1 and 30 degrees Celsius. This storage method helps maintain the effectiveness of the medication.
White round tablet
30 tablets / bottle, 100 tablets / bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowTerbinafine Hydrochloride 140.625mg
Tablet · Prescription medication
Nexpharm Korea Co., Ltd.
Terbinafine Hydrochloride 10mg
Cream · OTC medication
GP Therapeutics Korea Co., Ltd.
Terbinafine Hydrochloride 10mg
Cream · OTC medication
Korea Hutex Pharmaceutical Co., Ltd.
Terbinafine Hydrochloride 10mg
Cream · OTC medication
Anguk Pharmaceutical Co., Ltd.
Terbinafine Hydrochloride 10mg
Cream · OTC medication
Medica Korea Co., Ltd.
Terbinafine Hydrochloride 10mg
Cream · OTC medication
Gyeongnam Pharmaceutical Co., Ltd.
Terbinafine Hydrochloride 10mg
Cream · OTC medication
Daehwa Pharmaceutical Co., Ltd.
Terbinafine Hydrochloride 10mg
Cream · OTC medication
Korea Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.